Clinical trial
Measurement of Smoking-Induced Neutrophil Activation
NCT00159354 · Imperial College London, Other · Terminated
Key facts
| NCT number | NCT00159354 |
|---|---|
| Title | Measurement of Smoking-Induced Neutrophil Activation |
| Official title | Evaluation of Smoking-Induced Neutrophil Activation as a Potential Biomarker of Response to Therapeutic Interventions in COPD: Proof of Concept Study |
| Lead sponsor | Imperial College London, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | COPD |
| Intervention type | Drug |
| Interventions | predisolone |
| Enrollment | 16 |
| Start date | Jun 1, 2005 |
| Completion | Dec 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Oct 4, 2023 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: